Does the onset of bone metastasis in sunitinib-treated renal cell carcinoma patients impact the overall survival?
Author:
Publisher
Springer Science and Business Media LLC
Subject
Urology
Link
http://link.springer.com/content/pdf/10.1007/s00345-015-1707-0.pdf
Reference30 articles.
1. McKay RR, Lin X, Perkins JJ, Heng DY, Simantov R, Choueiri TK (2014) Prognostic significance of bone metastases and bisphosphonate therapy in patients with renal cell carcinoma. Eur Urol. doi: 10.1016/j.eururo.2014.02.040
2. Patil S, Figlin RA, Hutson TE, Michaelson MD, Negrier S, Kim ST, Huang X, Motzer RJ (2011) Prognostic factors for progression-free and overall survival with sunitinib targeted therapy and with cytokine as first-line therapy in patients with metastatic renal cell carcinoma. Ann Oncol 22(2):295–300. doi: 10.1093/annonc/mdq342
3. Toyoda Y, Shinohara N, Harabayashi T, Abe T, Akino T, Sazawa A, Nonomura K (2007) Survival and prognostic classification of patients with metastatic renal cell carcinoma of bone. Eur Urol 52(1):163–168. doi: 10.1016/j.eururo.2006.10.060
4. McKay RR, Kroeger N, Xie W, Lee JL, Knox JJ, Bjarnason GA, MacKenzie MJ, Wood L, Srinivas S, Vaishampayan UN, Rha SY, Pal SK, Donskov F, Tantravahi SK, Rini BI, Heng DY, Choueiri TK (2014) Impact of bone and liver metastases on patients with renal cell carcinoma treated with targeted therapy. Eur Urol 65(3):577–584. doi: 10.1016/j.eururo.2013.08.012
5. Motzer RJ, Escudier B, Bukowski R, Rini BI, Hutson TE, Barrios CH, Lin X, Fly K, Matczak E, Gore ME (2013) Prognostic factors for survival in 1059 patients treated with sunitinib for metastatic renal cell carcinoma. Br J Cancer 108(12):2470–2477. doi: 10.1038/bjc.2013.236
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Radiation therapy of renal cell carcinoma skeletal metastases – Does histologic subtype predict progression?;Clinical Surgical Oncology;2024-03
2. Primär oligometastasiertes Nierenzellkarzinom – Welchen Stellenwert hat heutzutage die Chirurgie?;Der Urologe;2021-11-04
3. Evolving cancer–niche interactions and therapeutic targets during bone metastasis;Nature Reviews Cancer;2021-10-05
4. Skeletal-Related Events in Patients with Metastatic Renal Cell Carcinoma: A Systematic Review;Kidney Cancer;2020-07-02
5. Does Bone-targeted Therapy Benefit Patients with Metastatic Renal Cell Carcinoma?;Translational Oncology;2020-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3